Amy B Vanatta
Examiner (ID: 17300, Phone: (571)272-4995 , Office: P/3765 )
Most Active Art Unit | 3765 |
Art Unit(s) | 2407, 3765, 3732, 2741, 3741, 3408 |
Total Applications | 2802 |
Issued Applications | 2004 |
Pending Applications | 180 |
Abandoned Applications | 618 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6323483
[patent_doc_number] => 20100196963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/547422
[patent_app_country] => US
[patent_app_date] => 2009-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20449
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196963.pdf
[firstpage_image] =>[orig_patent_app_number] => 12547422
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/547422 | Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro | Aug 24, 2009 | Issued |
Array
(
[id] => 5464980
[patent_doc_number] => 20090325180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/543875
[patent_app_country] => US
[patent_app_date] => 2009-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13736
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325180.pdf
[firstpage_image] =>[orig_patent_app_number] => 12543875
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543875 | Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells | Aug 18, 2009 | Abandoned |
Array
(
[id] => 8956242
[patent_doc_number] => 08502017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Rodent model of central neuropathic pain'
[patent_app_type] => utility
[patent_app_number] => 12/541754
[patent_app_country] => US
[patent_app_date] => 2009-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 6978
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12541754
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/541754 | Rodent model of central neuropathic pain | Aug 13, 2009 | Issued |
Array
(
[id] => 10888157
[patent_doc_number] => 08912153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'HDAC4 nucleic acid administration to treat retinal disease'
[patent_app_type] => utility
[patent_app_number] => 13/058346
[patent_app_country] => US
[patent_app_date] => 2009-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17385
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058346
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058346 | HDAC4 nucleic acid administration to treat retinal disease | Aug 12, 2009 | Issued |
Array
(
[id] => 6290206
[patent_doc_number] => 20100158975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'EXTRACELLULAR MATRIX COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/509171
[patent_app_country] => US
[patent_app_date] => 2009-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 20902
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158975.pdf
[firstpage_image] =>[orig_patent_app_number] => 12509171
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/509171 | Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions | Jul 23, 2009 | Issued |
Array
(
[id] => 8533635
[patent_doc_number] => 08309791
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-13
[patent_title] => 'Method for producing a transgenic pig using a hyper-methylated transposon'
[patent_app_type] => utility
[patent_app_number] => 12/504364
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19228
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12504364
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/504364 | Method for producing a transgenic pig using a hyper-methylated transposon | Jul 15, 2009 | Issued |
Array
(
[id] => 6527554
[patent_doc_number] => 20100015091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'MODIFIED STAT1 TRANSGENE THAT CONFERS INTERFERON HYPERRESPONSIVENESS, METHODS AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/504612
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 11686
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015091.pdf
[firstpage_image] =>[orig_patent_app_number] => 12504612
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/504612 | MODIFIED STAT1 TRANSGENE THAT CONFERS INTERFERON HYPERRESPONSIVENESS, METHODS AND USES THEREFOR | Jul 15, 2009 | Abandoned |
Array
(
[id] => 6413417
[patent_doc_number] => 20100166824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'EXTRACELLULAR MATRIX COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/501312
[patent_app_country] => US
[patent_app_date] => 2009-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20191
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166824.pdf
[firstpage_image] =>[orig_patent_app_number] => 12501312
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/501312 | EXTRACELLULAR MATRIX COMPOSITIONS | Jul 9, 2009 | Abandoned |
Array
(
[id] => 5468167
[patent_doc_number] => 20090328241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'MITOCHONDRIAL-NUCLEAR EXCHANGED CELLS, TISSUES, ORGANS AND ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 12/486375
[patent_app_country] => US
[patent_app_date] => 2009-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8173
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0328/20090328241.pdf
[firstpage_image] =>[orig_patent_app_number] => 12486375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/486375 | MITOCHONDRIAL-NUCLEAR EXCHANGED CELLS, TISSUES, ORGANS AND ANIMALS | Jun 16, 2009 | Abandoned |
Array
(
[id] => 7756519
[patent_doc_number] => 20120028821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'PROGRAMMING AND REPROGRAMMING OF CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/997815
[patent_app_country] => US
[patent_app_date] => 2009-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 34812
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028821.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997815
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997815 | Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides | Jun 14, 2009 | Issued |
Array
(
[id] => 4444334
[patent_doc_number] => 07863002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Breeding and milking cows for milk free of β-casein A1 '
[patent_app_type] => utility
[patent_app_number] => 12/484863
[patent_app_country] => US
[patent_app_date] => 2009-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 15543
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/863/07863002.pdf
[firstpage_image] =>[orig_patent_app_number] => 12484863
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/484863 | Breeding and milking cows for milk free of β-casein A1 | Jun 14, 2009 | Issued |
Array
(
[id] => 8375151
[patent_doc_number] => 08257941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Methods and platforms for drug discovery using induced pluripotent stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/484163
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 30774
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12484163
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/484163 | Methods and platforms for drug discovery using induced pluripotent stem cells | Jun 11, 2009 | Issued |
Array
(
[id] => 10184318
[patent_doc_number] => 09213999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-15
[patent_title] => 'Providing iPSCs to a customer'
[patent_app_type] => utility
[patent_app_number] => 12/484152
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23321
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12484152
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/484152 | Providing iPSCs to a customer | Jun 11, 2009 | Issued |
Array
(
[id] => 6382749
[patent_doc_number] => 20100316997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'Cell Markers for Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/483434
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4538
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0316/20100316997.pdf
[firstpage_image] =>[orig_patent_app_number] => 12483434
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/483434 | CBARA1 and LHX6 cell markers for embryonic stem cells | Jun 11, 2009 | Issued |
Array
(
[id] => 5397271
[patent_doc_number] => 20090317334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'OPTICAL DETECTION METHOD OR IMAGING METHOD OF IMPLANTED CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/481948
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7545
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317334.pdf
[firstpage_image] =>[orig_patent_app_number] => 12481948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/481948 | OPTICAL DETECTION METHOD OR IMAGING METHOD OF IMPLANTED CELLS | Jun 9, 2009 | Abandoned |
Array
(
[id] => 7540222
[patent_doc_number] => 08058065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'Oct3/4, Klf4, c-Myc and Sox2 produce induced pluripotent stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/457356
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 29475
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058065.pdf
[firstpage_image] =>[orig_patent_app_number] => 12457356
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/457356 | Oct3/4, Klf4, c-Myc and Sox2 produce induced pluripotent stem cells | Jun 8, 2009 | Issued |
Array
(
[id] => 5367845
[patent_doc_number] => 20090305404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Methods and compositions relating to blastomere-derived human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/455954
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9761
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305404.pdf
[firstpage_image] =>[orig_patent_app_number] => 12455954
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/455954 | Methods and compositions relating to blastomere-derived human embryonic stem cells | Jun 8, 2009 | Abandoned |
Array
(
[id] => 9823810
[patent_doc_number] => 08933295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'Identifying agents to treat alzheimer\'s disease-related decreased sorting behavior by administration to a triple transgenic mouse expressing mutant forms of APP, presenilin or tau'
[patent_app_type] => utility
[patent_app_number] => 12/993480
[patent_app_country] => US
[patent_app_date] => 2009-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8234
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993480
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993480 | Identifying agents to treat alzheimer's disease-related decreased sorting behavior by administration to a triple transgenic mouse expressing mutant forms of APP, presenilin or tau | Jun 2, 2009 | Issued |
Array
(
[id] => 5367088
[patent_doc_number] => 20090304647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Production of Neural Stem Cells from Bone Marrow Tissue and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/476029
[patent_app_country] => US
[patent_app_date] => 2009-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14937
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304647.pdf
[firstpage_image] =>[orig_patent_app_number] => 12476029
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/476029 | Production of Neural Stem Cells from Bone Marrow Tissue and Use Thereof | May 31, 2009 | Abandoned |
Array
(
[id] => 6371815
[patent_doc_number] => 20100075417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Methods and devices for isolating embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/454263
[patent_app_country] => US
[patent_app_date] => 2009-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6225
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075417.pdf
[firstpage_image] =>[orig_patent_app_number] => 12454263
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454263 | Methods and devices for isolating embryonic stem cells | May 13, 2009 | Abandoned |